Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> Posts navigation Older postsNewer posts